Unfortunately, GSK’s advertising tactics only serve to amplify fears and doubts sufferers may already have about antiretroviral therapy, making it harder for doctors to treat them, said Homayoon Khanlou, M.D., AHF’s Chief of Medication/U.S. It is necessary for sufferers and their companies to work together to create treatment decisions independent of medication industry advertising that may compromise the doctor/individual relationship and possibly the health of the patient. .. AIDS Healthcare Foundation blasts GlaxoSmithKline printing advertisements that promote fear of HIV treatment AIDS Healthcare Base is blasting Uk multi-national medication giant GlaxoSmithKline for a recent series of direct-to-consumer printing advertisements that, under the guise of patient education, capitalize on patients’ fears of HIV treatment.The denominator that was utilized to calculate the price of each outcome was the number of infants for whom that result was known. All analyses were conducted at the data center. Two-sided P values of less than 0.05 were considered to indicate statistical significance. Analyses of secondary outcomes did not consist of adjustment for multiple comparisons; nevertheless, for the 46 planned analyses of secondary outcomes according to treatment group, we’d expect no more than three assessments to have P ideals of significantly less than 0.05 on the basis of chance alone.